IBEX Technologies Past Earnings Performance
Past criteria checks 5/6
IBEX Technologies has been growing earnings at an average annual rate of 58%, while the Biotechs industry saw earnings growing at 12.7% annually. Revenues have been growing at an average rate of 14.1% per year. IBEX Technologies's return on equity is 27.9%, and it has net margins of 49.7%.
Key information
58.0%
Earnings growth rate
57.1%
EPS growth rate
Biotechs Industry Growth | 17.0% |
Revenue growth rate | 14.1% |
Return on equity | 27.9% |
Net Margin | 49.7% |
Last Earnings Update | 31 Jan 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How IBEX Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Jan 24 | 8 | 4 | 4 | 1 |
31 Oct 23 | 8 | 4 | 3 | 1 |
31 Jul 23 | 7 | 4 | 3 | 1 |
30 Apr 23 | 8 | 2 | 3 | 1 |
31 Jan 23 | 8 | 1 | 3 | 1 |
31 Oct 22 | 8 | 2 | 3 | 0 |
31 Jul 22 | 8 | 2 | 3 | 0 |
30 Apr 22 | 7 | 2 | 3 | 0 |
31 Jan 22 | 6 | 1 | 2 | 0 |
31 Oct 21 | 6 | 1 | 2 | 0 |
31 Jul 21 | 5 | 1 | 2 | 0 |
30 Apr 21 | 5 | 1 | 2 | 0 |
31 Jan 21 | 6 | 1 | 2 | 0 |
31 Oct 20 | 5 | 1 | 2 | 0 |
31 Jul 20 | 5 | 1 | 2 | 0 |
30 Apr 20 | 5 | 0 | 2 | 0 |
31 Jan 20 | 4 | -1 | 2 | 0 |
31 Oct 19 | 4 | -1 | 2 | 0 |
31 Jul 19 | 4 | -1 | 2 | 0 |
30 Apr 19 | 4 | -1 | 2 | 0 |
31 Jan 19 | 5 | 0 | 2 | 0 |
31 Oct 18 | 5 | 0 | 2 | 0 |
31 Jul 18 | 5 | 0 | 2 | 0 |
30 Apr 18 | 5 | 2 | 2 | 0 |
31 Jan 18 | 5 | 2 | 2 | 0 |
31 Oct 17 | 5 | 3 | 2 | 0 |
31 Jul 17 | 5 | 3 | 2 | 0 |
30 Apr 17 | 5 | 1 | 2 | 0 |
31 Jan 17 | 4 | 0 | 2 | 0 |
31 Oct 16 | 4 | 0 | 2 | 0 |
31 Jul 16 | 4 | 0 | 2 | 0 |
30 Apr 16 | 5 | 1 | 2 | 0 |
31 Jan 16 | 5 | 1 | 2 | 0 |
31 Oct 15 | 4 | 1 | 2 | 0 |
31 Jul 15 | 3 | 0 | 2 | 0 |
30 Apr 15 | 3 | -1 | 2 | 0 |
31 Jan 15 | 3 | -1 | 2 | 0 |
31 Oct 14 | 4 | 0 | 2 | 0 |
31 Jul 14 | 4 | 0 | 2 | 0 |
30 Apr 14 | 4 | 0 | 2 | 0 |
31 Jan 14 | 4 | 0 | 2 | 0 |
31 Oct 13 | 4 | 0 | 2 | 0 |
31 Jul 13 | 4 | 0 | 2 | 0 |
30 Apr 13 | 4 | -1 | 2 | 0 |
Quality Earnings: IBXN.F has a high level of non-cash earnings.
Growing Profit Margin: IBXN.F's current net profit margins (49.7%) are higher than last year (17.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IBXN.F's earnings have grown significantly by 58% per year over the past 5 years.
Accelerating Growth: IBXN.F's earnings growth over the past year (187.4%) exceeds its 5-year average (58% per year).
Earnings vs Industry: IBXN.F earnings growth over the past year (187.4%) exceeded the Biotechs industry -8.9%.
Return on Equity
High ROE: IBXN.F's Return on Equity (27.9%) is considered high.